Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.64 |
| ▸ | DGKA | P23743 | 1/20 | 0.64 |
| ▸ | HTR2C | P28335 | 1/20 | 0.61 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.58 |
| ▸ | RAD52 | P43351 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.54 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.54 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.54 |
| ▸ | FAAH | O00519 | 1/20 | 0.53 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | PAM | P19021 | 2/20 | 0.48 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19971885 | 1.00 | NAAA (0.64) | NAAADGKAHTR2CDNM1RAD52 | |
| SCHEMBL11169539 | 1.00 | NAAA (0.64) | NAAADGKAHTR2CDNM1RAD52 | |
| SCHEMBL679535 | 1.00 | NAAA (0.64) | NAAADGKAHTR2CDNM1RAD52 | |
| SCHEMBL2402731 | 1.00 | NAAA (0.64) | NAAADGKAHTR2CDNM1RAD52 | |
| SCHEMBL13864196 | 1.00 | NAAA (0.64) | NAAADGKAHTR2CDNM1RAD52 | |
| SCHEMBL1559306 | 1.00 | NAAA (0.64) | NAAADGKAHTR2CDNM1RAD52 | |
| SCHEMBL1557647 | 1.00 | NAAA (0.64) | NAAADGKAHTR2CDNM1RAD52 | |
| SCHEMBL7934038 | 1.00 | NAAA (0.64) | NAAADGKAHTR2CDNM1RAD52 | |
| SCHEMBL1557630 | 1.00 | NAAA (0.64) | NAAADGKAHTR2CDNM1RAD52 | |
| SCHEMBL17351200 | 1.00 | NAAA (0.64) | NAAADGKAHTR2CDNM1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137839-A1 | CONTROLLED HYDROGEL DELIVERY OF FOCAL ADHESION KINASE INHIBITOR FOR DECREASED SCAR FORMATION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2026-05-21 | — | — | US | claimed |
| US-12552713-B2 | Low-cost, effective phosphate-based lime bucking inhibitor | KNAUF GIPS KG (DE) | 2026-02-17 | — | — | US | claimed |
| US-12514810-B2 | Skin external composition comprising crosslinked hyaluronic acid gel | AMOREPACIFIC CORPORATION (KR) | 2026-01-06 | — | — | US | claimed |
| EP-4661921-A1 | WOUND DRESSING ASSEMBLY | Tautona Group Research And Development Company, L.L.C. (US) | 2025-12-17 | — | — | EP | claimed |
| US-20250361344-A1 | STYRENE BUTADIENE LATEX BINDER FOR WATERPROOFING APPLICATIONS | BASF SE (DE) | 2025-11-27 | — | — | US | claimed |
| US-12331169-B2 | Preparing a blend of polysaccharide and ingredient | CARGILL, INCORPORATED (US) | 2025-06-17 | — | — | US | claimed |
| EP-4551541-A1 | LOW-COST, EFFECTIVE PHOSPHATE-BASED LIME BUCKING INHIBITOR | Knauf Gips KG (DE) | 2025-05-14 | — | — | EP | claimed |
| CN-115785616-B | Epoxy resin based on modified POSS interpenetrating polymer network synergistic reinforcement and toughening and preparation method thereof | 中国科学院宁波材料技术与工程研究所 | 2025-05-09 | — | — | CN | claimed |
| WO-2025073346-A1 | A METHOD FOR PRODUCING STARCH POLYMER LIQUID MIXTURE | OMNIA EUROPE S.A. (RO) | 2025-04-10 | — | — | WO | claimed |
| WO-2025040469-A1 | USE OF SODIUM POLYPHOSPHATES IN AN INORGANIC MORTAR SYSTEM BASED ON ALUMINOUS CEMENT TO ACCELERATE CALCIUM ALUMINATE CEMENT HYDRATION | HILTI AKTIENGESELLSCHAFT (LI) | 2025-02-27 | — | — | WO | claimed |
| US-5587403-A | ACRYLATED POLYETHERURETHANE COPOLYMER | BORDEN, INC. (US) | 1996-12-24 | — | — | US | claimed |
| US-5527835-A | CURABLE ACRYLATED POLYETHERURETHANE WITH ACRYLATE MONOMERS, SILANE COUPLER AND PHOTOINITIATOR | BORDEN, INC. (US) | 1996-06-18 | — | — | US | claimed |
| EP-0566801-A2 | Organic solvent and water resistant, thermally, oxidatively and hydrolytically stable radiation-curable coatings for optical fibers, optical fibers coated therewith and processes for making same | BORDEN, INC. (US) | 1993-10-27 | — | — | EP | claimed |
| US-5146531-A | Acrylated polyurethane | BORDEN, INC. (US) | 1992-09-08 | — | — | US | claimed |
| US-4746559-A | MERCAPTO ESTERS | FUJI PHOTO FILM CO., LTD. (JP) | 1988-05-24 | — | — | US | claimed |
| EP-0199316-A2 | Chain-transfer agents for emulsion polymerization and polymer products produced therewith | PHILLIPS PETROLEUM COMPANY (US) | 1986-10-29 | — | — | EP | claimed |
| EP-0178115-A2 | Process for the production of heat resistant methacrylic resin | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-04-16 | — | — | EP | claimed |
| US-4233395-A | CONTAINING A MERCAPTAN TO PROMOTE ADHESION TO COPPER OR ITS ALLOY | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-11-11 | — | — | US | claimed |
| US-4016350-A | P-TOLUENESULFONIC ACID, STEARYL THIOGLYCOLATE, STEARYL 3-MERCAPTOPROPIONATE | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1977-04-05 | — | — | US | claimed |
| US-4013618-A | NITROGEN-CONTAINING STABILIZER | TOYOBO CO., LTD. (JA) | 1977-03-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552713-B2 | Low-cost, effective phosphate-based lime bucking inhibitor | DLST, TMCO1, CA2 | NAAA 1792/4885DGKA 1376/4885HTR2C 4244/4885 |
| US-20260137839-A1 | CONTROLLED HYDROGEL DELIVERY OF FOCAL ADHESION KINASE INHIBITOR FOR DECREASED SCAR FORMATION | PTK2, DSTYK, CTTN | NAAA 4015/4885DGKA 776/4885HTR2C 1125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.